Rarity Bioscience
Rarity Bioscience is a Swedish biotechnology company pioneering ultra-sensitive mutation detection for precision medicine. Proprietary superRCA® technology enables highly sensitive analysis of rare DNA variants in liquid biopsy and tissue samples. Partnering with pharmaceutical and biotechnology companies, we deliver tailored service projects, custom assay development and clinical study sample analysis. Experienced in supporting pharmaceutical research programs and exploratory biomarker analysis in clinical studies, we strengthen biomarker strategies, generate robust evidence and inform drug-development decisions across oncology and hematology.
